Education
About Us
Working with TipRanks
Follow Us
Michael Grosse Insider Profile
4 Followers
Michael Grosse, Chief Executive Officer at Sartorius, holds ― shares in Sartorius Stedim Biotech (Ticker: GB:0RG8), holds ― shares in Sartorius (Ticker: GB:0NIQ). Most recently, Michael Grosse Sold ― shares of Sartorius Stedim Biotech on Dec 15, 2025 for an estimated value of €158.32M.
Michael Grosse has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Michael Grosse does not currently own shares as a corporate insider.
A breakdown of Michael Grosse's holdings
Insider Roles
Roles that Michael Grosse holds in companies
Most Profitable Insider Trade
The most profitable trade made by Michael Grosse
Michael Grosse's Trading History
Sartorius
Jul 04, 2025
Chief Executive Officer
Uninformative Buy
―
―
Sartorius Stedim Biotech
Dec 15, 2025
Chairman & Chief Executive Officer
Informative Sell
158.32M
―
List of latest transactions for each holding click on a transaction to see Michael Grosse's performance on stock
You May Also Like
Michael Grosse insider profile FAQ
What is the percentage of profitable transactions made by Michael Grosse?
The percentage of profitable transactions made by Michael Grosse is ―.
What is the average return per transaction made by Michael Grosse?
The average return per transaction made by Michael Grosse is ―.
What stocks does Michael Grosse hold?
Michael Grosse holds: GB:0NIQ, GB:0RG8 stocks.
What was Michael Grosse’s latest transaction?
Michael Grosse latest transaction was an Informative Sell of €158.32M.
What was Michael Grosse's most profitable transaction?
Michael Grosse’s most profitable transaction was an Informative Sell of GB:0RG8 stock on December 15, 2025. The return on the trade was 0.60%.
What is Michael Grosse's role in Sartorius?
Michael Grosse's role in Sartorius is Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.